"Breast and endocrine" trang 1 - tải miễn phí từ tailieunhanh
Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR+) breast cancer

Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR+) breast cancer
9    1    1
Importance of endocrine treatment adherence and persistence in breast cancer survivorship: A systematic review

Importance of endocrine treatment adherence and persistence in breast cancer survivorship: A systematic review
12    1    1
Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: Study protocol of a randomized controlled trial

Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: Study protocol of a randomized controlled trial
10    46    1
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4

FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4
14    45    1
PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer

PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer
8    80    0
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: Results of the prospective observational EvAluate-TM study

Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: Results of the prospective observational EvAluate-TM study
9    86    0
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors

Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
13    100    0
Temporal influence of endocrine therapy with tamoxifen and chemotherapy on nutritional risk and obesity in breast cancer patients

Temporal influence of endocrine therapy with tamoxifen and chemotherapy on nutritional risk and obesity in breast cancer patients
11    47    1
Candidate methylation sites associated with endocrine therapy resistance in ER+/ HER2- breast cancer

Candidate methylation sites associated with endocrine therapy resistance in ER+/ HER2- breast cancer
15    34    1
Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data

Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data
12    50    1
Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy

Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy
13    40    1
An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: The ERA project

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: The ERA project
11    79    1
Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancer

Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancer
11    43    1
Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells

Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells
16    84    1
Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy

Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy
9    70    1
Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer

Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer
8    44    1
Adherence evaluation of endocrine treatment in breast cancer: Methodological aspects

Adherence evaluation of endocrine treatment in breast cancer: Methodological aspects
9    61    1
Comparison of fatigue and fatigability correlates in Korean breast cancer survivors and differences in associations with anxiety, depression, sleep disturbance, and endocrine symptoms: A randomized controlled trial

Comparison of fatigue and fatigability correlates in Korean breast cancer survivors and differences in associations with anxiety, depression, sleep disturbance, and endocrine symptoms: A randomized controlled trial
11    27    1
Comparative efficacy and safety of different combinations of three CDK4/6 inhibitors with endocrine therapies in HR+/HER2−metastatic or advanced breast cancer patients: A network meta-analysis

Comparative efficacy and safety of different combinations of three CDK4/6 inhibitors with endocrine therapies in HR+/HER2−metastatic or advanced breast cancer patients: A network meta-analysis
12    1    1
Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: A multicenter real-world study in the northwest of China

Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: A multicenter real-world study in the northwest of China
13    6    1